ArticleBMC medical informatics and decision making2025
Risk factors of breast cancer patients developing multiple primary cancers: a retrospective study and establishing/testing of machine learning models.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundBreast cancer is a prevalent malignancy globally, with approximately 1 in 10 breast cancer patients at risk of developing additional primary malignant tumors. This study seeks to explore the risk factors linked to the development of multiple primary cancers (MPCs) in breast cancer patients and to develop predictive models to aid in clinical decision-making.
methodsA cohort of patients from the Surveillance, Epidemiology, and End Results (SEER) database was analyzed to identify key factors contributing to the occurrence of MPCs. Machine learning models, including logistic regression and random forest, were established and tested to predict the risk of developing multiple primary cancers.
resultsA total of 120,434 breast cancer patients were included in the study. After random undersampling of the majority calss and random selected a quarter of populations, there were 3432 patients in each of the one primary breast cancer (OPBC) group and the MPCs group. A logistic regression and a random forest model were constructed based on age, marital status, laterality, histological type, tumor grade, American Joint Committee on Cance (AJCC) stage, T and N stage, molecular subtype, surgery, chemotherapy, and radiotherapy. The logistic regression model achieved an area under the curve (AUC) of 0.902, a specificity of 0.905, and a sensitivity of 0.767 in the training set, and an AUC of 0.886, a specificity of 0.882, and a sensitivity of 0.782 In the testing set. The random forest model achieved an AUC of 0.955, a specificity of 0.916, and a sensitivity of 0.859 in the training set, and an AUC of 0.874, a specificity of 0.858, and a sensitivity of 0.769 in the testing set. A nomogram was plotted based on the logistic regression model. The Kaplan-Meier (K-M) curves demonstrated statistically significant differences in prognosis among the various risk groups that were stratified based on the nomogram.
conclusionsThis study assessed several risk factors influencing the development of MPCs in breast cancer patients. The machine learning model could offer a practical tool for personalized risk assessment in this patient population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.